As a qui tam suit alleging fraud against one of the biggest private contractors for the multibillion-dollar Medicare Part D prescription-drug program heads toward discovery, a federal judge has defined the parameters for the discovery process.
http://www.law.com/jsp/pa/PubArticlePA.jsp?hubtype=MAIN_PAGE&id=1202597795807
http://www.law.com/jsp/pa/PubArticlePA.jsp?hubtype=MAIN_PAGE&id=1202597795807
No comments:
Post a Comment